BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 8158699)

  • 1. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
    Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
    J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.
    Sun XF; Carstensen JM; Zhang H; Arbman G; Nordenskjöld B
    Eur J Cancer; 1996 Oct; 32A(11):1963-7. PubMed ID: 8943682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.
    Bosari S; Viale G; Roncalli M; Graziani D; Borsani G; Lee AK; Coggi G
    Am J Pathol; 1995 Sep; 147(3):790-8. PubMed ID: 7677190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
    Manne U; Gary BD; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
    Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
    Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE
    Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.
    Buglioni S; D'Agnano I; Vasselli S; Perrone Donnorso R; D'Angelo C; Brenna A; Benevolo M; Cosimelli M; Zupi G; Mottolese M
    Am J Clin Pathol; 2001 Sep; 116(3):360-8. PubMed ID: 11554164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
    Lanza G; Maestri I; Dubini A; Gafa R; Santini A; Ferretti S; Cavazzini L
    Am J Clin Pathol; 1996 May; 105(5):604-12. PubMed ID: 8623770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Stål O; Zhang H; Nilsson E; Sjödahl R; Nordenskjöld B
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):443-8. PubMed ID: 8291217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II).
    Baretton GB; Vogt M; Müller C; Diebold J; Schneiderbanger K; Schmidt M; Löhrs U
    Scand J Gastroenterol; 1996 May; 31(5):481-9. PubMed ID: 8734346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
    Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
    Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
    Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variation in the prognostic value of p53 protein in relation to tumoral stage in patients with colorectal adenocarcinoma].
    Díez M; Pollán M; Ramos P; Villeta R; Ratia T; Hernández P; Lozano O; Noguerales F; Granell J
    Cir Esp; 2005 Apr; 77(4):213-20. PubMed ID: 16420920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas.
    Clausen OP; Lothe RA; Børresen-Dale AL; De Angelis P; Chen Y; Rognum TO; Meling GI
    Diagn Mol Pathol; 1998 Aug; 7(4):215-23. PubMed ID: 9917132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
    Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
    Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic influence of p53 nuclear overexpression in colorectal carcinoma.
    Gallego MG; Aceñero MJ; Ortega S; Delgado AA; Cantero JL
    Dis Colon Rectum; 2000 Jul; 43(7):971-5. PubMed ID: 10910245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.